Research and Development

Digital media is known to help create interaction and dialogue between groups and organisations, but new technology can also create …

London 2012 could provide a boost in the continuing search for personalised medicines for diabetes, heart disease and dementia as …

From humble beginnings in 2006 with six dedicated staff members and a vision to transform clinical trial support, the Medical …

Pfizer’s investigational arthritis drug tofacitinib has beaten methotrexate in a head-to-head study. Tofacitinib, an oral Janus kinase (JAK) inhibitor, is …

Ariad has filed its investigational blood cancer drug ponatinib with the FDA and hopes for an accelerated review. The US …

Shire has appointed Soren Tulstrup as its new senior vice president and franchise lead, MPS (mucopolysaccharides) for its human genetic …

A company specialising in novel treatments for Parkinson’s disease is the first to be spun out of Merck Serono’s soon-to-close …

David Meek has been appointed to the newly created position of chief commercial officer at the biotechnology firm Endocyte. Meek …

immatics’ investigational cancer vaccine has increased survival rates in patients with renal cell carcinoma. In a late-stage trial, the German …

The recent ruling by the US Supreme Court which upheld President Obama’s healthcare reforms could save the country around $84 …

The NHS Commissioning Board Authority has announced the appointment of the two director posts in the national leadership team of …

The European Commission has put forward new proposals aimed at revamping clinical trial laws. The legislation will replace rules that …

Parexel has launched the Parexel BioPharm Unit – a new division focused on the needs of small and mid-sized biopharma …

Late-stage biotech firm ADMA Biologics has announced it has appointed Lawrence Guiheen to its board of directors. Guiheen said: “Having …

Onyx’ Kyprolis has gained an accelerated approval by the FDA to treat patients with late-stage multiple myeloma.  Kyprolis (carfilzomib), a …